Exploratory research on efficacy and safety of transarterial chemo-embolization with warmed miriplatin for unresectable hepatocellular carcinoma
Not Applicable
Recruiting
- Conditions
- hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000027941
- Lead Sponsor
- The University of Tokyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1) severly impaired liver function (Child-Pugh C) 2) jaundice with T-bil >=3mg/dL 3) severely impaired renal function (eGFR < 30 mL/min/1.73m2) 4) past history with allergy or severe adverse events after TACE 5) marked history of hypersensitivity to miriplatin, other platinum-containing drugs or iodine-containing drugs 6) uncontrolled severe thyroid disorder 7) pregnant, lactating 8) dementia with difficuty conducting TACE 9) patients judged inadequate by investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method